STOCK TITAN

Emergent Biosolutions Inc - EBS STOCK NEWS

Welcome to our dedicated news page for Emergent Biosolutions (Ticker: EBS), a resource for investors and traders seeking the latest updates and insights on Emergent Biosolutions.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Emergent Biosolutions's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Emergent Biosolutions's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.6%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.7%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.86%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.1%
Tags
clinical trial
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
conferences
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.97%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.55%
Tags
earnings
Emergent Biosolutions Inc

NYSE:EBS

EBS Rankings

EBS Stock Data

135.21M
51.22M
2.89%
79.79%
9.41%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Gaithersburg

About EBS

emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent